SILK (Silk Road Medical Inc.) Short-Term Debt to Capital

Silk Road Medical, Inc. (SILK) creates innovative stroke prevention methods using a patented blood flow diversion system for carotid artery surgeries. This technological foundation, combined with specialized stents, has turned their platform into a widely recognized safety benchmark in surgery. This chart of the current share price demonstrates an asset bolstered by intellectual property protection and the support of a global medtech behemoth, with the indicator standing at 0.08.

This metric assesses the proportion of liabilities maturing within one year relative to equity, where the value 0.08 reflects the current level of financial leverage; by analyzing the short-term debt-to-equity chart, an investor determines liquidity risk, which is critical for Silk Road Medical, Inc (SILK) when financing high-tech partnerships with surgeons to implement ENROUTE systems for stroke minimization.